TABLE 3.
Nucleotide and amino acid diversity of HSV-2 strains in open reading frames
| ORF | Protein functiona | Orientationb | Length (bp) (nucleic acid reference sequence) | % Diversity (SE) |
dN/dS | No. of variable sites | |
|---|---|---|---|---|---|---|---|
| Nucleotide | Amino acid | ||||||
| UL1 | Glycoprotein L | F | 675 | 0.1 (0.0) | 0.2 (0.1) | 1.00 | 10 |
| UL2 | Uracil-DNA glycosylase | F | 1,005 | 0.2 (0.0) | 0.2 (0.1) | 0.25 | 20 |
| UL3 | Nuclear phosphoprotein | F | 702 | 0.1 (0.0) | 0.0 (0.0) | 0.00 | 7 |
| UL4 | Nuclear protein | R | 606 | 0.3 (0.2) | 0.3 (0.2) | 0.17 | 13 |
| UL5 | Component of DNA helicase-primase | R | 2,646 | 0.2 (0.0) | 0.1 (0.1) | 0.25 | 28 |
| UL6 | Minor capsid protein | F | 2,043 | 0.2 (0.0) | 0.3 (0.1) | 0.33 | 33 |
| UL7 | Virion egress protein | F | 891 | 0.4 (0.1) | 0.4 (0.2) | 0.20 | 16 |
| UL8 | Component of DNA helicase-primase | R | 2,259 | 0.3 (0.1) | 0.3 (0.1) | 0.40 | 47 |
| UL9 | Ori binding protein | R | 2,608 | 0.2 (0.0) | 0.1 (0.1) | 0.20 | 42 |
| UL10 | Glycoprotein M | F | 1,404 | 0.2 (0.1) | 0.2 (0.1) | 0.14 | 26 |
| UL11 | Myristylated tegument protein | R | 291 | 0.1 (0.1) | 0.3 (0.2) | 1.00 | 4 |
| UL12 | DNase | R | 1,863 | 0.2 (0.0) | 0.3 (0.1) | 0.33 | 31 |
| UL13 | Protein kinase; tegument protein | R | 1,496 | 0.2 (0.0) | 0.1 (0.0) | 0.00 | 19 |
| UL14 | Tegument protein | R | 660 | 0.0 (0.0) | 0.0 (0.0) | 0.00 | 4 |
| UL15 | Role in DNA packaging | F | 5,862 | 0.1 (0.0) | 0.2 (0.0) | 0.50 | 70 |
| UL16 | Proposed initiator CTG codon | R | 1,119 | 0.1 (0.1) | 0.2 (0.1) | 0.50 | 12 |
| UL17 | Tegument protein; DNA packaging | R | 2,118 | 0.2 (0.0) | 0.3 (0.1) | 0.67 | 29 |
| UL18 | Capsid protein | R | 957 | 0.1 (0.0) | 0.0 (0.0) | 0.00 | 6 |
| UL19 | Major capsid protein | R | 4,125 | 0.1 (0.0) | 0.1 (0.0) | 0.50 | 45 |
| UL20 | Virion membrane protein | R | 669 | 0.2 (0.1) | 0.6 (0.3) | 3.00 | 6 |
| UL21 | Tegument protein | F | 1,599 | 0.0 (0.0) | 0.0 (0.0) | 0.00 | 6 |
| UL22 | Glycoprotein H | R | 2,517 | 0.3 (0.1) | 0.3 (0.1) | 0.17 | 39 |
| UL23 | Thymidine kinase [2 possible poly(A) sites] | R | 1,131 | 0.2 (0.1) | 0.3 (0.1) | 1.00 | 16 |
| UL24 | Nuclear protein | F | 846 | 0.4 (0.1) | 0.4 (0.2) | 0.22 | 21 |
| UL25 | Virion protein | F | 1,758 | 0.1 (0.0) | 0.1 (0.0) | 0.00 | 20 |
| UL26 | Capsid maturation protease | F | 1,923 | 0.3 (0.1) | 0.4 (0.1) | 0.29 | 55 |
| UL26.5 | Capsid assembly protein | F | 990 | 0.4 (0.1) | 0.6 (0.2) | 0.38 | 39 |
| UL27 | Glycoprotein B | R | 2,718 | 0.2 (0.0) | 0.5 (0.1) | 0.67 | 45 |
| UL28 | Role in DNA packaging | R | 2,358 | 0.2 (0.0) | 0.2 (0.1) | 0.17 | 36 |
| UL29 | Single-stranded DNA binding protein | R | 3,609 | 0.2 (0.0) | 0.2 (0.1) | 0.14 | 61 |
| UL30 | DNA polymerase catalytic subunit | F | 3,723 | 0.1 (0.0) | 0.1 (0.0) | 0.50 | 32 |
| UL31 | Virion egress protein | R | 918 | 0.1 (0.0) | 0.0 (0.0) | 0.00 | 11 |
| UL32 | Role in DNA packaging | R | 1,797 | 0.2 (0.1) | 0.3 (0.1) | 0.17 | 29 |
| UL33 | Role in DNA packaging | F | 393 | 0.2 (0.1) | 0.1 (0.1) | 0.00 | 4 |
| UL34 | Membrane-associated phosphoprotein | F | 831 | 0.1 (0.1) | 0.2 (0.2) | 0.50 | 7 |
| UL35 | Capsid protein | F | 339 | 0.1 (0.0) | 0.1 (0.1) | 0.00 | 4 |
| UL36 | Very large tegument protein | R | 9,412 | 0.2 (0.0) | 0.2 (0.0) | 0.25 | 160 |
| UL37 | Tegument protein | R | 3,345 | 0.1 (0.0) | 0.2 (0.1) | 0.50 | 43 |
| UL38 | Capsid protein | F | 1,401 | 0.4 (0.1) | 0.4 (0.1) | 0.22 | 36 |
| UL39 | Ribonucleotide reductase large subunit | F | 3,441 | 0.4 (0.1) | 0.5 (0.1) | 0.18 | 97 |
| UL40 | Ribonucleotide reductase small subunit | F | 1,014 | 0.1 (0.0) | 0.0 (0.0) | 0.00 | 11 |
| UL41 | Tegument protein; host shutoff factor | R | 1,479 | 0.1 (0.0) | 0.1 (0.1) | 0.00 | 14 |
| UL42 | DNA polymerase subunit | F | 1,413 | 0.2 (0.1) | 0.4 (0.1) | 1.00 | 18 |
| UL43 | Probable membrane protein | F | 1,245 | 0.3 (0.1) | 0.4 (0.1) | 0.40 | 22 |
| UL44 | Glycoprotein C | F | 1,443 | 0.4 (0.1) | 0.7 (0.2) | 0.80 | 24 |
| UL45 | Tegument/envelope protein | F | 519 | 0.1 (0.0) | 0.1 (0.1) | 1.00 | 5 |
| UL46 | Tegument protein | R | 2,169 | 0.3 (0.1) | 0.4 (0.1) | 0.33 | 40 |
| UL47 | Tegument protein | R | 2,091 | 0.1 (0.0) | 0.3 (0.1) | 1.00 | 26 |
| UL48 | Tegument protein; transactivator of immediate-early genes | R | 1,473 | 0.2 (0.1) | 0.1 (0.1) | 0.00 | 17 |
| UL49 | Tegument protein | R | 912 | 0.5 (0.1) | 0.8 (0.3) | 0.40 | 26 |
| UL49A | Probable virion membrane protein | R | 264 | 0.4 (0.2) | 0.2 (0.1) | 0.07 | 7 |
| UL50 | Deoxyuridine triphosphatase | F | 1,110 | 0.2 (0.1) | 0.3 (0.1) | 0.25 | 23 |
| UL51 | Tegument protein | R | 735 | 0.1 (0.1) | 0.0 (0.0) | 0.00 | 5 |
| UL52 | Component of DNA helicase-primase | F | 3,204 | 0.2 (0.0) | 0.3 (0.1) | 0.25 | 49 |
| UL53 | Glycoprotein K | F | 1,017 | 0.4 (0.1) | 0.7 (0.2) | 0.50 | 27 |
| UL54 | ICP27 immediate-early regulatory protein | F | 1,539 | 0.1 (0.0) | 0.2 (0.1) | 0.50 | 22 |
| UL55 | Nuclear protein | F | 561 | 0.1 (0.0) | 0.2 (0.1) | 0.50 | 7 |
| UL56 | Membrane protein | R | 708 | 0.2 (0.1) | 0.4 (0.2) | 0.50 | 13 |
| US1 | ICP4 immediate-early transactivator | F | 1,239 | 0.4 (0.1) | 0.4 (0.2) | 0.38 | 32 |
| US2 | Virion protein | F | 873 | 0.2 (0.1) | 0.4 (0.2) | 0.50 | 11 |
| US3 | Protein kinase | F | 1,443 | 0.2 (0.1) | 0.3 (0.1) | 0.25 | 22 |
| US4 | Glycoprotein G | F | 2,097 | 0.4 (0.1) | 0.7 (0.1) | 1.00 | 61 |
| US5 | Glycoprotein J | F | 276 | 0.2 (0.1) | 0.2 (0.1) | 0.17 | 9 |
| US6 | Glycoprotein D | F | 1,179 | 0.2 (0.0) | 0.3 (0.1) | 0.25 | 17 |
| US7 | Glycoprotein I | F | 1,116 | 0.3 (0.1) | 0.6 (0.2) | 0.75 | 24 |
| US8 | Glycoprotein E | F | 1,635 | 0.2 (0.0) | 0.4 (0.1) | 1.00 | 29 |
| US9 | Tegument protein | F | 267 | 0.4 (0.2) | 0.2 (0.1) | 0.08 | 6 |
| US10 | Virion protein | R | 906 | 0.3 (0.1) | 0.4 (0.2) | 0.40 | 16 |
| US11 | RNA binding protein | R | 453 | 0.2 (0.1) | 0.5 (0.3) | 1.00 | 7 |
| US12 | Immediate-early inhibitor of antigen presentation | R | 258 | 0.2 (0.1) | 0.0 (0.0) | 0.00 | 2 |
Reference 1.
F, forward; R, reverse.